Matches in Nanopublications for { ?s ?p "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP803668.RAczZYupzIt95dczywhISXtBCP8NXXecYUns01RxOqRJs130_assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803668.RAczZYupzIt95dczywhISXtBCP8NXXecYUns01RxOqRJs130_provenance.
- NP376450.RAtiNZdxOVIolOLJOzUCpQhaf78A52ybF9GMaeFIU7WkI130_assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376450.RAtiNZdxOVIolOLJOzUCpQhaf78A52ybF9GMaeFIU7WkI130_provenance.
- NP803674.RAt4Z2Zeb1Y_T2x6Q_LMprcYf4MoYs_33CtbsbNDePVi4130_assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803674.RAt4Z2Zeb1Y_T2x6Q_LMprcYf4MoYs_33CtbsbNDePVi4130_provenance.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.